| Literature DB >> 33328345 |
Alessia Volpe1, Veronica L Nagle2, Jason S Lewis1,2,3, Vladimir Ponomarev4,2,3.
Abstract
Chimeric antigen receptor (CAR)-T cell therapy has generated unprecedented advances in the treatment of hematologic cancers, but readily translatable imaging approaches to visualize the in vivo dynamics of CAR-T cells are lacking. Noninvasive PET imaging is the ideal tool to monitor CAR-T cells.See related article by Simonetta et al., p. 1058. ©2020 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33328345 PMCID: PMC7887102 DOI: 10.1158/1078-0432.CCR-20-4297
Source DB: PubMed Journal: Clin Cancer Res ISSN: 1078-0432 Impact factor: 13.801